Cargando…
Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing
Concerns over cardiac side effects are the largest single cause of compound attrition during pharmaceutical drug development. For a number of years, biophysically detailed mathematical models of cardiac electrical activity have been used to explore how a compound, interfering with specific ion-chann...
Autores principales: | Mirams, Gary R, Davies, Mark R, Cui, Yi, Kohl, Peter, Noble, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492977/ https://www.ncbi.nlm.nih.gov/pubmed/22568589 http://dx.doi.org/10.1111/j.1476-5381.2012.02020.x |
Ejemplares similares
-
Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator
por: McMillan, Beth, et al.
Publicado: (2017) -
Moderate but not severe hypothermia causes pro-arrhythmic changes in cardiac electrophysiology
por: Dietrichs, Erik S, et al.
Publicado: (2020) -
Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk
por: Davies, Mark R., et al.
Publicado: (2020) -
The Cardiac Electrophysiology Web Lab
por: Cooper, Jonathan, et al.
Publicado: (2016) -
Representation of Multiple Cellular Phenotypes Within Tissue-Level Simulations of Cardiac Electrophysiology
por: Bowler, Louise A., et al.
Publicado: (2018)